269 related articles for article (PubMed ID: 33122722)
1. Double-in vitro maturation increases the number of vitrified oocytes available for fertility preservation when ovarian stimulation is unfeasible.
Sermondade N; Grynberg M; Comtet M; Valdelievre C; Sifer C; Sonigo C
Sci Rep; 2020 Oct; 10(1):18555. PubMed ID: 33122722
[TBL] [Abstract][Full Text] [Related]
2. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
3. Immature oocyte retrieval and in vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment.
Creux H; Monnier P; Son WY; Tulandi T; Buckett W
Fertil Steril; 2017 Jan; 107(1):198-204. PubMed ID: 27810160
[TBL] [Abstract][Full Text] [Related]
4. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response.
Volodarsky-Perel A; Cohen Y; Arab S; Son WY; Suarthana E; Dahan MH; Tulandi T; Buckett W
Hum Reprod; 2019 Mar; 34(3):530-538. PubMed ID: 30689898
[TBL] [Abstract][Full Text] [Related]
6. In vitro maturation of immature oocytes from ovarian tissue prior to shipment to a cryobank.
Dietrich JE; Jauckus J; Hoffmann S; Liebenthron J; Capp E; Strowitzki T; Germeyer A
Arch Gynecol Obstet; 2020 Oct; 302(4):1019-1024. PubMed ID: 32556511
[TBL] [Abstract][Full Text] [Related]
7. Priming Before In Vitro Maturation Cycles in Cancer Patients Undergoing Urgent Fertility Preservation: a Randomized Controlled Study.
Sonigo C; Le Conte G; Boubaya M; Ohanyan H; Pressé M; El Hachem H; Cedrin-Durnerin I; Benoit A; Sifer C; Sermondade N; Grynberg M
Reprod Sci; 2020 Dec; 27(12):2247-2256. PubMed ID: 32617881
[TBL] [Abstract][Full Text] [Related]
8. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
9. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
10. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
11. Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification.
Shalom-Paz E; Almog B; Shehata F; Huang J; Holzer H; Chian RC; Son WY; Tan SL
Reprod Biomed Online; 2010 Oct; 21(4):566-71. PubMed ID: 20822957
[TBL] [Abstract][Full Text] [Related]
12. Serum antimüllerian hormone is associated with the number of oocytes matured in vitro and with primordial follicle density in candidates for fertility preservation.
Sermondade N; Sonigo C; Sifer C; Valtat S; Ziol M; Eustache F; Grynberg M
Fertil Steril; 2019 Feb; 111(2):357-362. PubMed ID: 30527837
[TBL] [Abstract][Full Text] [Related]
13. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
14. Thirteen years' experience in fertility preservation for cancer patients after in vitro fertilization and in vitro maturation treatments.
Creux H; Monnier P; Son WY; Buckett W
J Assist Reprod Genet; 2018 Apr; 35(4):583-592. PubMed ID: 29502188
[TBL] [Abstract][Full Text] [Related]
15. Oocyte cryopreservation with in vitro maturation for fertility preservation in girls at risk for ovarian insufficiency.
Gayete-Lafuente S; Turan V; Oktay KH
J Assist Reprod Genet; 2023 Dec; 40(12):2777-2785. PubMed ID: 37715873
[TBL] [Abstract][Full Text] [Related]
16. Oncofertility case report: live birth 10 years after oocyte in vitro maturation and zygote cryopreservation.
Rodrigues P; Marques M; Pimentel S; Rato M; Carvalho P; Correia SC; Mendes N; Amaral H; Fernandes JP; Carvalho MJ; Plancha CE
J Assist Reprod Genet; 2020 Dec; 37(12):3089-3094. PubMed ID: 33113072
[TBL] [Abstract][Full Text] [Related]
17. Combination of ovarian tissue harvesting and immature oocyte collection for fertility preservation increases preservation yield.
Hourvitz A; Yerushalmi GM; Maman E; Raanani H; Elizur S; Brengauz M; Orvieto R; Dor J; Meirow D
Reprod Biomed Online; 2015 Oct; 31(4):497-505. PubMed ID: 26278808
[TBL] [Abstract][Full Text] [Related]
18. Oocyte vitrification for fertility preservation in women with endometriosis: an observational study.
Cobo A; Giles J; Paolelli S; Pellicer A; Remohí J; García-Velasco JA
Fertil Steril; 2020 Apr; 113(4):836-844. PubMed ID: 32145929
[TBL] [Abstract][Full Text] [Related]
19. In vitro maturation is a viable option for urgent fertility preservation in young women with hematological conditions.
Sonigo C; Bajeux J; Boubaya M; Eustache F; Sifer C; Lévy V; Grynberg M; Sermondade N
Hematol Oncol; 2020 Oct; 38(4):560-564. PubMed ID: 32065670
[TBL] [Abstract][Full Text] [Related]
20. Is in vitro maturation of oocytes retrieved ex vivo from ovarian tissue an effective fertility preservation technique in the presence of organic ovarian cysts?
Bourg M; Moreau J; Carles M; Cadoret F; Lesourd F; Tournier A; Léandri RD; Gatimel N
Eur J Obstet Gynecol Reprod Biol; 2023 Feb; 281():87-91. PubMed ID: 36586210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]